State Board of Administration of Florida Retirement System’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.02M Sell
157,558
-4,810
-3% -$263K 0.02% 645
2026
Q1
$9.17M Sell
162,368
-1,438
-0.9% -$83.8K 0.02% 592
2025
Q4
$9.73M Sell
163,806
-18,737
-10% -$1.02M 0.02% 587
2025
Q3
$9.89M Sell
182,543
-11,499
-6% -$658K 0.02% 584
2025
Q2
$10.7M Buy
194,042
+1,910
+1% +$112K 0.02% 561
2025
Q1
$13.6M Sell
192,132
-6,010
-3% -$404K 0.03% 483
2024
Q4
$13M Sell
198,142
-7,147
-3% -$479K 0.02% 508
2024
Q3
$14.4M Sell
205,289
-4,641
-2% -$388K 0.03% 494
2024
Q2
$17.3M Sell
209,930
-6,344
-3% -$528K 0.03% 423
2024
Q1
$21M Buy
216,274
+2,884
+1% +$258K 0.05% 363
2023
Q4
$20.6M Sell
213,390
-8,068
-4% -$714K 0.04% 384
2023
Q3
$19.6M Buy
221,458
+298
+0.1% +$26.5K 0.05% 367
2023
Q2
$19.2M Buy
221,160
+4,886
+2% +$460K 0.04% 394
2023
Q1
$21M Buy
216,274
+2,000
+0.9% +$207K 0.05% 368
2022
Q4
$22.2M Buy
214,274
+2,130
+1% +$200K 0.05% 343
2022
Q3
$18M Sell
212,144
-3,470
-2% -$309K 0.05% 383
2022
Q2
$17.9M Sell
215,614
-12,681
-6% -$1.01M 0.04% 403
2022
Q1
$17.6M Sell
228,295
-4,763
-2% -$399K 0.03% 481
2021
Q4
$20.6M Sell
233,058
-2,486
-1% -$205K 0.04% 452
2021
Q3
$18.2M Sell
235,544
-5,971
-2% -$471K 0.04% 471
2021
Q2
$20.2M Sell
241,515
-25,560
-10% -$2.03M 0.04% 460
2021
Q1
$20.2M Sell
267,075
-11,540
-4% -$943K 0.04% 438
2020
Q4
$24.4M Buy
278,615
+11,860
+4% +$940K 0.05% 358
2020
Q3
$20.3M Buy
266,755
+140
+0.1% +$14.2K 0.05% 369
2020
Q2
$32.9M Buy
266,615
+27,031
+11% +$2.69M 0.08% 237
2020
Q1
$20.2M Buy
239,584
+149
+0.1% +$12.8K 0.06% 292
2019
Q4
$20.2M Sell
239,435
-3,290
-1% -$248K 0.05% 361
2019
Q3
$16.4M Buy
242,725
+986
+0.4% +$75.9K 0.04% 413
2019
Q2
$20.7M Sell
241,739
-4,732
-2% -$405K 0.05% 346
2019
Q1
$21.9M Sell
246,471
-650
-0.3% -$60.2K 0.06% 325
2018
Q4
$21M Sell
247,121
-2,129
-0.9% -$203K 0.06% 302
2018
Q3
$24.2M Sell
249,250
-2,664
-1% -$266K 0.06% 310
2018
Q2
$23.7M Buy
251,914
+90
+0% +$7.88K 0.06% 307
2018
Q1
$20.4M Sell
251,824
-7,843
-3% -$673K 0.06% 344
2017
Q4
$23.2M Buy
259,667
+471
+0.2% +$41K 0.06% 312
2017
Q3
$24.1M Buy
259,196
+5,030
+2% +$444K 0.07% 292
2017
Q2
$23.1M Buy
254,166
+2,521
+1% +$229K 0.07% 304
2017
Q1
$22.1M Buy
251,645
+613
+0.2% +$54.5K 0.06% 310
2016
Q4
$20.8M Buy
251,032
+7,518
+3% +$647K 0.06% 309
2016
Q3
$22.5M Sell
243,514
-350
-0.1% -$33K 0.07% 288
2016
Q2
$19M Buy
243,864
+41,143
+20% +$3.5M 0.06% 328
2016
Q1
$16.7M Sell
202,721
-7,840
-4% -$638K 0.06% 303
2015
Q4
$22.1M Sell
210,561
-2,836
-1% -$296K 0.08% 248
2015
Q3
$22.5M Buy
213,397
+2,594
+1% +$346K 0.09% 234
2015
Q2
$28.8M Buy
210,803
+9,306
+5% +$1.15M 0.1% 205
2015
Q1
$25.1M Sell
201,497
-8,265
-4% -$876K 0.09% 247
2014
Q4
$19M Sell
209,762
-1,565
-0.7% -$130K 0.06% 331
2014
Q3
$15.2M Sell
211,327
-2,032
-1% -$134K 0.05% 379
2014
Q2
$13.3M Buy
213,359
+5,847
+3% +$353K 0.04% 446
2014
Q1
$14.2M Sell
207,512
-15,367
-7% -$1.13M 0.05% 406
2013
Q4
$15.7M Buy
222,879
+1,360
+0.6% +$92.4K 0.05% 399
2013
Q3
$16M Buy
221,519
+2,840
+1% +$189K 0.05% 377
2013
Q2
$12.2M Buy
+218,679
New +$13.6M 0.04% 449

Other funds holding BMRN

State Board of Administration of Florida Retirement System's BMRN Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System reduced its BioMarin Pharmaceuticals (BMRN) stake by 3% in Q2 2026, selling an estimated $263K and leaving 157,558 shares worth $9.02M. The position accounts for 0.02% of the portfolio, ranked #645.

State Board of Administration of Florida Retirement System first reported a position in BMRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $32.9M in Q2 2020. 272 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 157,558 shares of BioMarin Pharmaceuticals worth $9.02M as of Q2 2026.
  • State Board of Administration of Florida Retirement System sold 4,810 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $263K.
  • BioMarin Pharmaceuticals made up 0.02% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #645 holding.
  • State Board of Administration of Florida Retirement System first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • State Board of Administration of Florida Retirement System's BioMarin Pharmaceuticals position peaked at $32.9M in Q2 2020.
  • 272 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.